ATE314349T1 - Pyroglutaminsäure-salz von amlodipin - Google Patents
Pyroglutaminsäure-salz von amlodipinInfo
- Publication number
- ATE314349T1 ATE314349T1 AT03018653T AT03018653T ATE314349T1 AT E314349 T1 ATE314349 T1 AT E314349T1 AT 03018653 T AT03018653 T AT 03018653T AT 03018653 T AT03018653 T AT 03018653T AT E314349 T1 ATE314349 T1 AT E314349T1
- Authority
- AT
- Austria
- Prior art keywords
- amlodipine
- acid salt
- pyroglutamine acid
- pyroglutamine
- chem
- Prior art date
Links
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000528 amlodipine Drugs 0.000 title abstract 2
- NPWMTBZSRRLQNJ-VKHMYHEASA-N (3s)-3-aminopiperidine-2,6-dione Chemical compound N[C@H]1CCC(=O)NC1=O NPWMTBZSRRLQNJ-VKHMYHEASA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical class OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2002-0049422A KR100467669B1 (ko) | 2002-08-21 | 2002-08-21 | 암로디핀의 유기산염 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE314349T1 true ATE314349T1 (de) | 2006-01-15 |
Family
ID=36643418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03018653T ATE314349T1 (de) | 2002-08-21 | 2003-08-20 | Pyroglutaminsäure-salz von amlodipin |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6846931B2 (de) |
| EP (1) | EP1391453B1 (de) |
| JP (1) | JP4319491B2 (de) |
| KR (1) | KR100467669B1 (de) |
| CN (1) | CN1289482C (de) |
| AT (1) | ATE314349T1 (de) |
| AU (1) | AU2003256108A1 (de) |
| DE (1) | DE60302951T2 (de) |
| WO (1) | WO2004018426A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005042485A1 (en) * | 2003-10-30 | 2005-05-12 | Sk Chemicals, Co., Ltd. | Acid added salts of amlodipine |
| DE102004025373A1 (de) * | 2004-05-24 | 2005-12-15 | Merck Patent Gmbh | Maschinenlesbares Sicherheitselement für Sicherheitserzeugnisse |
| EP1695973A1 (de) * | 2005-02-24 | 2006-08-30 | Neuro3D | Ocaperidonsalz und dieser enthaltende pharmazeutische Zubereitung |
| KR101501253B1 (ko) * | 2014-12-22 | 2015-03-12 | 제이투에이치바이오텍 (주) | 결정성 페북소스타트 피돌레이트 염 및 이의 제조 방법 |
| CN104529877A (zh) * | 2015-01-22 | 2015-04-22 | 华东理工常熟研究院有限公司 | 氨氯地平-癸酸离子液体及其制备方法和用途 |
| EP3960158B1 (de) | 2016-10-07 | 2025-05-21 | Silvergate Pharmaceuticals, Inc. | Amlodipinformulierungen |
| EP3532457B1 (de) * | 2017-07-31 | 2020-03-18 | Small Pharma Ltd | Kristalline formen von hydroxynorketamine |
| CN112334134A (zh) | 2018-04-11 | 2021-02-05 | 希沃盖特制药公司 | 氨氯地平制剂 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US86888A (en) * | 1869-02-09 | Improved clothes-pin | ||
| DK161312C (da) | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
| GB8608335D0 (en) | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
| GB8710493D0 (en) * | 1987-05-02 | 1987-06-03 | Pfizer Ltd | Dihydropyridines |
| US4758569A (en) | 1987-08-26 | 1988-07-19 | Pfizer Inc. | Doxazosin as an anti-atherosclerosis agent |
| KR930006256B1 (ko) | 1989-12-28 | 1993-07-09 | 주식회사 코오롱 | 폴리에스테르 결합제의 제조방법 |
| US6057344A (en) | 1991-11-26 | 2000-05-02 | Sepracor, Inc. | Methods for treating hypertension, and angina using optically pure (-) amlodipine |
| AT399718B (de) * | 1992-04-16 | 1995-07-25 | Lek Tovarna Farmacevtskih | Inklusionskomplexe von optisch aktiven und racemischen 1,4-dihydropyridinen mit methyl-beta- cyclodextrin oder anderen cyclodextrinderivaten, ein verfahren zur herstellung von optisch aktiven dihydropyridinen und deren inklusionskomplexen und diese komplexe enthaltende pharmazeutische formulierungen |
| KR100188391B1 (ko) * | 1993-08-27 | 1999-06-01 | 류정열 | 전기자동차의 충전중 표시 장치 |
| KR100217240B1 (ko) * | 1996-10-31 | 1999-09-01 | 조생현 | 암로디핀 베실레이트의 제조방법 |
| PL189666B1 (pl) | 1998-04-09 | 2005-09-30 | Adamed Sp Z Oo | Sposób otrzymywania benzenosulfonianu amlodypiny |
| JP3590966B2 (ja) | 1999-02-22 | 2004-11-17 | 豊和工業株式会社 | ロッドレスシリンダ |
| UA72768C2 (en) * | 1999-07-05 | 2005-04-15 | Richter Gedeon Vegyeszet | A method for obtaining amilodipine benzenesulphonate |
| CA2433181C (en) | 2000-12-29 | 2005-11-22 | Pfizer Limited | Amlodipine hemifumarate |
| RS53403A (sr) | 2000-12-29 | 2006-10-27 | Pfizer Limited | Postupak za dobijanje amlodipin maleata |
| BR0116553A (pt) * | 2000-12-29 | 2004-02-03 | Pfizer Ltd | Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão |
| KR100462304B1 (ko) * | 2002-07-30 | 2004-12-17 | 씨제이 주식회사 | 암로디핀의 유기산염 |
-
2002
- 2002-08-21 KR KR10-2002-0049422A patent/KR100467669B1/ko not_active Expired - Fee Related
-
2003
- 2003-08-19 US US10/642,754 patent/US6846931B2/en not_active Expired - Fee Related
- 2003-08-20 EP EP03018653A patent/EP1391453B1/de not_active Expired - Lifetime
- 2003-08-20 DE DE60302951T patent/DE60302951T2/de not_active Expired - Lifetime
- 2003-08-20 AT AT03018653T patent/ATE314349T1/de not_active IP Right Cessation
- 2003-08-21 AU AU2003256108A patent/AU2003256108A1/en not_active Abandoned
- 2003-08-21 CN CNB031649564A patent/CN1289482C/zh not_active Expired - Fee Related
- 2003-08-21 WO PCT/KR2003/001677 patent/WO2004018426A1/en not_active Ceased
- 2003-08-21 JP JP2003297765A patent/JP4319491B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004018426A1 (en) | 2004-03-04 |
| KR20040017380A (ko) | 2004-02-27 |
| DE60302951T2 (de) | 2006-07-20 |
| DE60302951D1 (de) | 2006-02-02 |
| AU2003256108A1 (en) | 2004-03-11 |
| KR100467669B1 (ko) | 2005-01-24 |
| CN1289482C (zh) | 2006-12-13 |
| CN1495166A (zh) | 2004-05-12 |
| JP4319491B2 (ja) | 2009-08-26 |
| US6846931B2 (en) | 2005-01-25 |
| EP1391453B1 (de) | 2005-12-28 |
| JP2004131483A (ja) | 2004-04-30 |
| US20040158075A1 (en) | 2004-08-12 |
| EP1391453A1 (de) | 2004-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20040564L (no) | Karboksylsyrederivatforbindelser og legemidler omfattende disse forbindelser som den aktive bestanddel | |
| NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
| DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
| EE200100487A (et) | Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena | |
| FI950309A0 (fi) | Proliiniamidijohdannaisia | |
| ATE245152T1 (de) | Dioxocyclopentylhydroxamsäure | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| DK1004578T3 (da) | 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater | |
| NO20043367L (no) | Oralt farmasoytisk preparat | |
| PL368519A1 (pl) | Kompozycje farmaceutyczne amlodypiny i atorwastatyny | |
| HN2002000332A (es) | Sales de acido succinico de 5,7,14 triazatetraciclo (10. 3.1.02.11.04,9)-hexadeca-2 (11), 3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas | |
| BG106128A (bg) | Обща сол на aмлодипин и аторвастатин | |
| ATE454385T1 (de) | Hiv-integrase-hemmers, pharmazeutischen zusammensetzung und ihre anwendung | |
| EE200200591A (et) | Püridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks ühenditeks | |
| SE0102440D0 (sv) | New compound | |
| DE60302951D1 (de) | Pyroglutaminsäure-salz von Amlodipin | |
| WO2003024933A1 (en) | 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same | |
| ATE253359T1 (de) | Antithrombotische mittel | |
| HUP0600084A2 (en) | Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient | |
| DK1666473T3 (da) | Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens | |
| HUP0500164A3 (en) | Heterocyclic substituted benzenesulfonamides as hiv protease inhibitors and pharmaceutical compositions containing them | |
| DE69828522D1 (de) | Antithrombotische mittel | |
| EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
| BR0313076A (pt) | Sal de ácido orgânico de amlodipina | |
| DE60205504D1 (de) | Zitronensäure salz von einer therapeutischen verbindung und deren pharmazeutischen zusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |